SHS Capital invests in leading German endoscopy group

Tübin­gen — Health­care specia­list SHS Capi­tal is inves­t­ing in a leading German endo­scopy group via the SHS VI fund. The group consists of the compa­nies EMOS Tech­no­logy, Inno­View, ILO elec­tro­nic and Micon Medi­zin­tech­nik and forms a struc­tu­red succes­sion solu­tion for foun­der and mana­ging direc­tor Frank Spillner. 

The Endo­scopy Group is one of the few Euro­pean manu­fac­tu­r­ers of endo­scopy systems with in-house deve­lo­p­ment and a high level of verti­cal inte­gra­tion. The broad and inno­va­tive product port­fo­lio includes reusable rigid, semi-flexi­­ble and flexi­ble endo­sco­pes as well as camera systems, light sources and insuf­fla­tors. The products meet the growing global demand for mini­mally inva­sive proce­du­res in a wide range of applications. 

The Group has grown stron­gly in recent years and has been able to launch new, inno­va­tive products on the market every year. All key stages of the value chain, from optics produc­tion to final assem­bly, take place at modern sites in Germany. In addi­tion, the Group is charac­te­ri­zed by strong tech­ni­cal exper­tise, short deve­lo­p­ment cycles, high flexi­bi­lity and a very high level of custo­mer loyalty. The Group’s custo­mers are prima­rily natio­nal and inter­na­tio­nal OEM custo­mers and distributors. 

The invest­ment by SHS crea­tes a struc­tu­red succes­sion solu­tion for foun­der and Mana­ging Direc­tor Frank Spill­ner via a multi-stage concept. In the coming years, SHS will accom­pany the Endo­scopy Group as a growth part­ner, with a focus on expan­ding rela­ti­onships with exis­ting custo­mers, further inter­na­tio­na­liza­tion, the deve­lo­p­ment of addi­tio­nal products and the further streng­thening of the compa­nies’ posi­tion as an inte­gra­ted platform. 

“In SHS, we have found a long-term orien­ted part­ner with proven MedTech exper­tise who under­stands our busi­ness model and shares our vision of an inte­gra­ted endo­scopy plat­form,” explains Frank Spill­ner. “The invest­ment enables us to invest in inno­va­tion, manu­fac­tu­ring and inter­na­tio­nal market deve­lo­p­ment while imple­men­ting a struc­tu­red succes­sion solu­tion for the endo­scopy divi­sion that actively preser­ves our DNA as a relia­ble, leading quality ‘Made in Germany’ manufacturer.” 

“The Endo­scopy Group is one of the few Euro­pean manu­fac­tu­r­ers that covers the entire spec­trum of endo­sco­pes, imaging and access­ories with its own verti­cal range of manu­fac­ture, thus posi­tio­ning itself as a stra­te­gic part­ner for OEMs and distri­bu­tors world­wide,” says Tobias Fuchs (photo: SHS), Senior Invest­ment Mana­ger at SHS Capi­tal. “On this basis, we want to deve­lop a leading Euro­pean plat­form in endo­scopy toge­ther with the ambi­tious manage­ment and further scale the inter­na­tio­nal business.”